Rate My Professor Morten Thaysen-Andersen

Thaysen-Andersen obtained his PhD from the University of Southern Denmark, completing his doctoral studies from November 2006 to February 2010. He subsequently undertook a postdoctoral fellowship at Macquarie University from February 2010 to February 2012. Since July 2014, he has served as Group Leader at the university, progressing to his current professorial position. He is the recipient of an Australian Research Council (ARC) Future Fellowship, active from 2016 to 2026. His scholarly impact is evidenced by over 7,046 citations on Google Scholar, reflecting his contributions to fields such as glycobiology, glycoproteomics, mass spectrometry, glycoimmunology, and pathogen infection. Among his prominent publications are "Compositional data analysis enables statistical rigor in comparative glycomics" (Nature Communications, 2025), "Serum AGP-1-Lex glycoforms report on survivorship of patients with septic shock upon admission to intensive care unit" (Molecular & Cellular Proteomics, 2026), "A novel glycoform of the rotavirus outer capsid protein VP7 is secreted from polarized cells and activates innate immune cells" (Journal of Virology, 2026), and his co-authorship in the "Update and new implementation of the MIRAGE reporting guidelines for mass spectrometry experiments in glycoscience" (Molecular & Cellular Proteomics, 2026). Thaysen-Andersen is involved with Macquarie's Multi-Omics Research Centre, Biomolecular Discovery Research Centre, and the ARC Industrial Transformation Training Centre for Facilitated Advancement of Australia's Bioactives (FAAB). He also holds the position of President on the Board of Directors of the Australian Glycobiology Society.